Upper Respiratory Symptoms Research Study
Currently it is challenging to distinguish viral infections that cannot be treated with antibiotics from bacterial infections which do respond to antibiotics. Clinical Research Associates in Nashville, TN is conducting a research study to test a diagnostic device. This device is designed to identify your body's immune response to a viral and/or bacterial respiratory infection. This study is looking for participants who have symptoms of an upper respiratory infection, such as:
Participants will be testing the new device. The office visit will require a blood draw, finger prick, and swabbing of throat and nose.
The office visit takes less than 1 hour and compensation at time of visit is $100.
Condition | Common Cold, Influenza, Bronchitis |
---|---|
Clinical Study Identifier | TX137803 |
Sponsor | Rapid Pathogen |
Last Modified on | 23 November 2020 |
,
You have contacted , on
Your message has been sent to the study team at ,
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreEvery year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Congrats! You have your own personal workspace now.